$2.840
-0.151 (-5.33%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ELTX Prediction & Forecast by Similar Chart Analysis
Alphio's ELTX stock price prediction model matches the current Elicio Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.79 (-1.86%). The 1-week path is $3.05 (+7.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Elicio Therapeutics Inc Stock?
Elicio Therapeutics Inc is currently not a strong buy due to its recent performance and financial challenges. The stock is priced at $2.84, significantly down from its highs, and the RSI is at 25, indicating oversold conditions. However, the company has a forward P/E ratio of 0, and analysts have set a price target as high as $23, suggesting potential recovery. The main risk is the ongoing clinical trial setbacks, with a net income loss of $11.8 million reported in Q1 2026, which raises concerns about its financial stability.
ELTX stock price ended at $2.84 on Friday, after losing -5.33%
Elicio Therapeutics Inc (ELTX) last closed at $2.84, losing -5.33%. These facts feed the 1-day and 1-week ELTX price prediction above.
Forecast Drivers
Elicio Therapeutics Inc (ELTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ELTX, ranked by similarity.
Seasonality analysis for ELTX
Historically the probability of a positive August return for ELTX is 33.33%. May offers the highest probability of a positive month at 95.24%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ELTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $9.02 | $9.58 | $10.03 | +237.45% |
| Sep 2026 | $10.32 | $11.05 | $13.25 | +288.98% |
| Oct 2026 | $7.74 | $8.34 | $8.47 | +193.52% |
| Nov 2026 | $6.98 | $8.97 | $10.72 | +215.95% |
| Dec 2026 | $10.58 | $11.28 | $13.43 | +297.11% |
In 2026, Elicio Therapeutics Inc (ELTX) is projected to range from $6.98 to $13.43.
Elicio Therapeutics Inc 2026 monthly forecast
In Aug 2026, Elicio Therapeutics Inc is projected to average $9.58, with a low of $9.02 and high of $10.03.
In Sep 2026, Elicio Therapeutics Inc is projected to average $11.05, with a low of $10.32 and high of $13.25.
In Oct 2026, Elicio Therapeutics Inc is projected to average $8.34, with a low of $7.74 and high of $8.47.
In Nov 2026, Elicio Therapeutics Inc is projected to average $8.97, with a low of $6.98 and high of $10.72.
In Dec 2026, Elicio Therapeutics Inc is projected to average $11.28, with a low of $10.58 and high of $13.43.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.